BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Solve ME/CFS Initiative - ECPv6.15.17//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://solvecfs.org
X-WR-CALDESC:Events for Solve ME/CFS Initiative
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260908T150000
DTEND;TZID=America/Los_Angeles:20260908T160000
DTSTAMP:20260715T170042
CREATED:20260512T140700Z
LAST-MODIFIED:20260512T140700Z
UID:43935-1788879600-1788883200@solvecfs.org
SUMMARY:A Safe\, Accessible Treatment for ME/CFS? The Mitochondrial Stabilizer IVO-21 Study
DESCRIPTION:As part of our commitment to advancing science that brings real hope to people living with ME/CFS or Long Covid\, Solve has selected Dr. Jay H. Chung (National Institutes of Health) as a recipient of our latest ME/CFS Catalyst Award. \nDr. Chung’s groundbreaking study\, “Mitochondrial Stabilizer IVO-21 As Therapy for ME/CFS\,” is focused on developing a new way to restore cellular energy production by targeting two of the most debilitating and poorly treated aspects of ME/CFS and Long Covid—mitochondrial dysfunction and chronic inflammation—mechanisms believed to drive symptoms such as fatigue and brain fog. \nThe compound at the heart of this study is IVO\, an inexpensive small-molecule therapy that can be easily taken as pills. Early results in cell-culture models suggest IVO restores mitochondrial energy production and reduces systemic inflammation. The next step is to evaluate how well IVO alleviates sickness behavior in preclinical (mouse) models. \nIn this free educational webinar hosted by Solve Vice President of Scientific Programs Dr. Jessica Maya\, Dr. Chung will explain why his research is an essential step toward future clinical studies that could benefit millions and how it could pave the way for a safe\, accessible treatment that addresses the root causes of these complex diseases. \nRegister here.
URL:https://solvecfs.org/event/a-safe-accessible-treatment-for-me-cfs-the-mitochondrial-stabilizer-ivo-21-study/
CATEGORIES:Research,Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2026/05/Sept8DrChung.png
END:VEVENT
END:VCALENDAR